Clinical and immunological improvement in a patient who received thalidomide treatment for refractory Mycobacterium avium complex infection

Clin Infect Dis. 1998 Jan;26(1):184-5. doi: 10.1086/517054.

Authors

A Gori¹, F Franzetti, G Marchetti, C Rossi, M L Fusi, S Ruzzante, M Clerici

Affiliation

¹ Infectious Diseases Clinic, L. Sacco Hospital, University of Milan, Italy.

PMID: 9455531
DOI: 10.1086/517054

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Immunocompromised Host
Middle Aged
Mycobacterium avium-intracellulare Infection / drug therapy*
Mycobacterium avium-intracellulare Infection / immunology
Thalidomide / therapeutic use*
Tumor Necrosis Factor-alpha / biosynthesis

Substances

Tumor Necrosis Factor-alpha
Thalidomide